OraSure Technologies, Inc.
NASDAQ:OSURMedical - Instruments & Supplies
-$0.16 today
- Market cap
- $247.88M
- Beta
- 1.01
- P/E (TTM)
- -4.0
- EPS (TTM)
- -$1.08
Volume 0.49M
Average 0.61M
OSUR EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
OraSure Technologies, Inc.NASDAQ: OSUR
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA remains negative
Q1 FY2026 EBITDA was -$20.47M, compared with -$13.73M a year earlier. Trailing-twelve-month EBITDA was -$63.7M.
Context
- EBITDA amounted to 49.5% of revenue in FY2025, up 45.8 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 1 analysts of -$33.39M (+41.4%) for the fiscal year ending Dec 2026, a step up from the -734.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$20.47M-22.8% QoQ
- Last fiscal yearDec 2025
- -$56.96M-734.1% YoY
- LTMMar 2026
- -$63.7M-188.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -49.1% | -5.9% | +43.2 pp |
| 1 year | -734.1% | +41.4% | +775.5 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (56.96M) USD
- Year-over-year change
- -734.1%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (56.96M) | -734.1% |
| FY2024 | 2024-12-31 | (6.83M) | -109.0% |
| FY2023 | 2023-12-31 | 76.16M | +4646.7% |
| FY2022 | 2022-12-31 | (1.68M) | -170.8% |
| FY2021 | 2021-12-31 | 2.37M | — |
EBITDA vs competitors
How OSUR compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -188.7% is the lowest of 9, against a peer median of -0.0%.
- EBITDA amounts to 56.4% of revenue for OSUR, versus a peer median of 123.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $16.36M USD | -9.1% | -15.0% | 43.6% | |
| LTM Mar 2026 | -$25.7M USD | +34.0% | — | 17.0% | |
| LTM Mar 2026 | -$35.22M USD | — | — | — | |
| LTM Mar 2026 | -$37.85M USD | +9.1% | — | 200.6% | |
| LTM Mar 2026 | -$50.77M USD | +11.7% | — | — | |
| LTM Mar 2026 | -$51.68M USD | +9.1% | — | 45.4% | |
| LTM Mar 2026 | -$62.94M USD | -39.6% | — | — | |
| LTM Mar 2026 | -$63.7M USD | -188.7% | — | 56.4% | |
| LTM Mar 2026 | -€77.16M EUR | -21.4% | — | 472.8% | |
| LTM Mar 2026 | -$110.64M USD | -31.7% | — | 17902.8% | |
| Peer median (excluding OSUR) | — | -0.0% | -15.0% | 123.0% | |
Competitors are the stored peer set for OSUR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 233.67M | 387.48M | 405.47M | 185.83M | 115.02M |
| Cost of Revenue | 116.07M | 239.04M | 226.05M | 109.6M | 66.82M |
| Gross Profit | 117.6M | 148.44M | 179.42M | 76.23M | 48.2M |
| Gross Margin | 50.3% | 38.3% | 44.2% | 41.0% | 41.9% |
| Research & Development | 34.17M | 36.24M | 33.16M | 24.42M | 42.53M |
| Selling, General & Admin | 95.08M | 117.44M | 92.18M | 72.41M | 73.79M |
| Operating Expenses | 129.25M | 153.68M | 125.34M | 96.83M | 116.32M |
| Depreciation & Amortization | 11.66M | 14M | 19.9M | 10.87M | 9.97M |
| EBITDA | 2.37M | (1.68M) | 76.16M | (6.83M) | (56.96M) |
| EBITDA Margin | 1.0% | -0.4% | 18.8% | -3.7% | -49.5% |
| Operating Income | (11.65M) | (5.24M) | 54.08M | (20.6M) | (68.12M) |
| Operating Margin | -5.0% | -1.4% | 13.3% | -11.1% | -59.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 2.36M | (10.43M) | 2.18M | 2.9M | 1.19M |
| Income Before Tax | (9.29M) | (15.68M) | 56.26M | (17.7M) | (66.93M) |
| Pre-Tax Margin | -4.0% | -4.0% | 13.9% | -9.5% | -58.2% |
| Income Tax Expense | 13.71M | 1.46M | 2.6M | 1.8M | 1.8M |
| Net Income | (23M) | (17.13M) | 53.66M | (19.5M) | (68.73M) |
| Net Margin | -9.8% | -4.4% | 13.2% | -10.5% | -59.8% |
| EPS (Basic) | (0.32) | (0.25) | 0.73 | (0.26) | (0.94) |
| EPS (Diluted) | (0.32) | (0.25) | 0.72 | (0.26) | (0.94) |
| Weighted Avg Shares | 71.98M | 72.51M | 73.35M | 74.43M | 73.49M |
| Weighted Avg Shares (Diluted) | 71.98M | 72.51M | 74.39M | 74.43M | 73.49M |
OraSure Technologies, Inc.
NASDAQ:OSUR
Intrinsic Alpha fair value
Locked
Current Price
$3.59
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.